ATS Blue Journal
@atsblueeditor.bsky.social
2K followers 65 following 590 posts
Posting content from the American Journal of Respiratory and Critical Care Medicine; follows do not indicate endorsement. #pulmCC #sleepmed #AJRCCM #RespEd #ATS #medsky https://www.atsjournals.org/journal/ajrccm
Posts Media Videos Starter Packs
Pinned
atsblueeditor.bsky.social
📣Call for Papers! 📣

Looking for articles highlighting the spectrum of discovery in thoracic malignancies

📅Deadline: October 28, 2025

🔬Learn More Here: tinyurl.com/yc3f9r7y

🖱️Submit here: tinyurl.com/3h7dmm2x
@atscommunity.bsky.social @ats-toa.bsky.social #medsky
Reposted by ATS Blue Journal
atscommunity.bsky.social
What role does AI play in training the next generation of doctors? As Kaele Leonard, MD, Vanderbilt University School of Medicine, explains on this ep of the ATS Breathe Easy podcast, there's still value to learning to do procedures without AI assistance.

Watch now: www.youtube.com/watch?v=VQSh...
atsblueeditor.bsky.social
The Blue Journal thanks Jonathan Rayment, MDCM, MSc, FRCPC, for his contribution to the October issue

Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Children ≥6 Years with Cystic Fibrosis and at Least One F508del Allele

www.atsjournals.org/doi/full/10....
atsblueeditor.bsky.social
Performance Characteristics for Physiological Measures of Progressive Pulmonary Fibrosis

Standalone lung function decline provides better mortality discrimination and similar net benefit for antifibrotic initiation than PPF guideline criteria
#medsky

🔗 tinyurl.com/msypy54w
atsblueeditor.bsky.social
Progress in Progressive Pulmonary Fibrosis
@atscommunity.bsky.social #medsky

🔓 Open Access

🔗 tinyurl.com/mnt2ejy8
atsblueeditor.bsky.social
Thanks to Rachel Linnemann, MD, for her contribution to the October issue

Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Adults and Adolescents with Cystic Fibrosis and at Least One F508del Allele
@emory-choa-cfair.bsky.social

www.atsjournals.org/doi/full/10....
atsblueeditor.bsky.social
A 10,000-Foot View at Survival and Treatment with Phosphodiesterase-5 Inhibitors in Interstitial Lung Disease Pulmonary Hypertension
@atscommunity.bsky.social #medsky

🔓 Open Access

🔗 tinyurl.com/32xvxtpf
atsblueeditor.bsky.social
Hemodynamics and Phosphodiesterase-5 Inhibitor Treatment Associated with Survival in Pulmonary Hypertension in Interstitial Lung Disease: A PVRI GoDeep Meta-Registry Analysis
@atscommunity.bsky.social #medsky

🔗 tinyurl.com/yeu6f7tv
atsblueeditor.bsky.social
The Blue Journal thanks Ashwatha Thenappan, MD, for her contribution to the October issue

Performance Characteristics for Physiological Measures of Progressive Pulmonary Fibrosis

www.atsjournals.org/doi/full/10....
atsblueeditor.bsky.social
Particulate Matter Associations with Lung Function in Pulmonary Sarcoidosis

Studying long-term effects of air pollution may guide air quality standards and regulations for vulnerable populations
@pittdeptofmed.bsky.social
@atscommunity.bsky.social #medsky

🔗 tinyurl.com/36xbdkem
atsblueeditor.bsky.social
🎙️ Just published a new episode of Out of the Blue: An AJRCCM Podcast: Outcomes of a Typical Fibrotic Hypersensitivity Pneumonitis Pattern on Chest Computed Tomography and Rethinking the Computed Tomography and Histopathological Nomenclature of Hypersensitivity Pneumonitis. Have a listen:
Outcomes of a Typical Fibrotic Hypersensitivity Pneumonitis Pattern on Chest Computed Tomography and Rethinking the Computed Tomography and Histopathological Nomenclature of Hypersensitivity Pneumonitis
Dr. Mohleen Kang chats with Dr. Chris Ryerson, Dr. Johannson, and Dr....
share.transistor.fm
atsblueeditor.bsky.social
The Blue Journal thanks Athiththan Yogeswaran, MD, for his contribution to the October issue

Hemodynamics and Phosphodiesterase-5 Inhibitor Treatment Associated with Survival in Pulmonary Hypertension in ILD: A PVRI GoDeep Meta-Registry Analysis

www.atsjournals.org/doi/full/10....
atsblueeditor.bsky.social
Epigenome-Wide Analysis Identifies Pollution-Sensitive Loci in Fibrotic Interstitial Lung Disease

PM2.5 and its constituents are associated with differential DNA methylation in the blood of patients with fibrotic ILD
@gilliangoobie.bsky.social #medsky

🔗 tinyurl.com/2rk6wwmn
atsblueeditor.bsky.social
The Blue Journal thanks Sharon E. Kim, BS, for her contribution to the October issue

Particulate Matter Associations with Lung Function in Pulmonary Sarcoidosis

@pittdeptofmed.bsky.social
www.atsjournals.org/doi/full/10....
atsblueeditor.bsky.social
Active Antigen-Specific Adaptive Immune Responses Are Shared among Patients with Progressive Fibrotic Interstitial Lung Disease
@atscommunity.bsky.social #medsky

🔗 tinyurl.com/mr25hrvt
Reposted by ATS Blue Journal
atscommunity.bsky.social
How can asthma experts best inform their colleagues of the uses of anti-inflammatory therapies? Njira Lugogo, MD, of University of Michigan Health, explains all of the tools she implements on this latest episode of the ATS Breathe Easy podcast.

Watch the episode now: www.youtube.com/watch?v=dXiP...
atsblueeditor.bsky.social
The Blue Journal thanks Vaibhav Upadhyay, MD, PhD, for his contribution to the October issue

Active Antigen-Specific Adaptive Immune Responses Are Shared among Patients with Progressive Fibrotic Interstitial Lung Disease

www.atsjournals.org/doi/full/10....
atsblueeditor.bsky.social
Associations of High Attenuation Area–Related Proteomic Biomarkers with Fibrotic or Subpleural Interstitial Lung Abnormalities
@jskim8223.bsky.social @atscommunity.bsky.social #medsky

🔗 tinyurl.com/da3jsx8n
atsblueeditor.bsky.social
Who Will Evolve from Interstitial Lung Abnormalities to Interstitial Lung Disease? Early Radio-Proteomic Warning Signals in the Lung
@atscommunity.bsky.social #medsky

🔓 Open Access

🔗 tinyurl.com/fx4aj5br
atsblueeditor.bsky.social
The Blue Journal thanks Tania Estefania Velez, PhD, for her contribution to the October issue

Active Antigen-Specific Adaptive Immune Responses Are Shared among Patients with Progressive Fibrotic Interstitial Lung Disease

www.atsjournals.org/doi/full/10....
atsblueeditor.bsky.social
Outcomes of a Typical Fibrotic Hypersensitivity Pneumonitis Pattern on Chest Computed Tomography

Patients with a typical fibrotic hypersensitivity pneumonitis (HP) pattern on chest CT frequently have non-HP diagnoses
@atscommunity.bsky.social #medsky

🔗 tinyurl.com/36cnkake
atsblueeditor.bsky.social
Rethinking the Computed Tomography and Histopathological Nomenclature of Hypersensitivity Pneumonitis: Unveiling Bronchiolocentric Patterns of Interstitial Pneumonia
@atscommunity.bsky.social #medsky

🔓 Open Access

🔗 tinyurl.com/5ys59a96
atsblueeditor.bsky.social
The Blue Journal thanks Riley Hannan, PhD, for his contribution to the October issue

Associations of High Attenuation Area-Related Proteomic Biomarkers with Fibrotic or Subpleural Interstitial Lung Abnormalities
@jskim8223.bsky.social

www.atsjournals.org/doi/full/10....